AbbVie's strong financials and potential for cash flow make it a valuable investment, despite risks from patent expirations.

This month, we explore the 125-year-old history of Abbott Laboratories and its most significant milestone to date – the creation of its own independent company, AbbVie. In 1888, a 30-year-old ...

When it comes to dividend investing, there are two basic paths you can take. You could seek out businesses that are raising ...

In its latest attempt to bulk up its cancer drug portfolio, AbbVie has signed a new licensing agreement with China-based Simcere Zaiming to develop a treatment for myeloma, a type of blood cancer ...